It is a poorly kept secret in the world of clinical trials that issues with patient recruitment and enrollment are the primary causes for missing clinical trial timelines.  Most of us have seen the data. We know that for each day a company goes beyond the planned deadline for a clinical trial, that company could be losing as much as $600,000 in foregone sales of smaller products and as much as $8 million on blockbuster drugs. As necessity is the mother of invention, it comes as no surprise that sponsors and CROs are looking to any and all means by which to increase the rate of patient enrollment.
View File